RU2015105561A - SUBSTITUTED HETEROAZEPINONES - Google Patents
SUBSTITUTED HETEROAZEPINONES Download PDFInfo
- Publication number
- RU2015105561A RU2015105561A RU2015105561A RU2015105561A RU2015105561A RU 2015105561 A RU2015105561 A RU 2015105561A RU 2015105561 A RU2015105561 A RU 2015105561A RU 2015105561 A RU2015105561 A RU 2015105561A RU 2015105561 A RU2015105561 A RU 2015105561A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- methyl
- oxo
- aryl
- methylamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
Abstract
1. Соединение формулыв которомW и X одинаковы или различны и независимо выбраны из Н, С-алкила, гидрокси-С-алкила, арил-С-алкила, С-циклоалкил-С-алкила, С-алкенил-С-алкила, С-алкинил-С-алкила и гетероцикла илиX и W совместно с атомом азота, к которому они присоединены, могут образовывать С-гетероцикл, или W совместно с атомом азота, к которому он присоединен, и Y совместно с атомом углерода, к которому он присоединен, могут образовывать С-гетероцикл;Y представляет собой d-6-алкил, гидрокси-С-алкил или С-циклоалкил-С-алкил;R1 выбран из Н, галогена, C-алкила, галоген-С-алкила, арил-С-алкила, С-циклоалкил-С-алкила, СООН, C(O)NR8′R9′, ацила, OR7, SR7, NR8R9, N-ацила, N-сульфонила, цианогруппы и SOR10;Rвыбран из Н, галогена, C-алкила, арил-С-алкила, С-циклоалкил-C-алкила, ацила, OR7, SR7, NR8R9, N-ацила, N-сульфонила, цианогруппы и SOR10;R3 выбран из Н, галогена, C-алкила, галоген-С-алкила, арил-С-алкила, С-циклоалкил-С-алкила, ацила, OR7, SR7, NR8R9, N-ацила, N-сульфонила, цианогруппы и SOR10;R4 представляет собой Н или C-алкил;R5 и R6 одинаковы или различны и независимо выбраны из Н, С-алкила, С-алкил-S-С-алкила, С-алкил-О-С-алкила, арила и С-циклоалкила илиR5 и R6 совместно с атомом углерода, к которому они присоединены, могут образовывать С-карбоцикл или гетероцикл, который, возможно, замещен группой C-алкил-SO;V представляет собой S, О или SO,Z выбран из C-алкила,арила, возможно замещенного С-циклоалкилом, C-алкилом, C-алкоксигруппой, галогеном, галоген-С-алкоксигруппой, С(O)N(С-алкил,С-алкил), C(O)NHSO-C-алкилом, С(O)N(С-алкил,гидрокси-С-алкил), С(O)N(С-алкил,СООН-С-алкил), фенилом, возможно замещенным цианогруппой, COO-C-алкилом или СООН; арил-С-алкила,гетероарила, возможно замещенного цианогруппой, C-алкоксигруппой или фенилом, возможно замещенным группой С(O)N(Н,С-алкил), цианогруппой или COOH,полициклических ароматических1. A compound of the formula wherein W and X are the same or different and independently selected from H, C-alkyl, hydroxy-C-alkyl, aryl-C-alkyl, C-cycloalkyl-C-alkyl, C-alkenyl-C-alkyl, C- alkynyl-C-alkyl and heterocycle or X and W together with the nitrogen atom to which they are attached can form a C-heterocycle, or W together with the nitrogen atom to which it is attached, and Y together with the carbon atom to which it is attached, can form a C-heterocycle; Y represents d-6-alkyl, hydroxy-C-alkyl or C-cycloalkyl-C-alkyl; R1 is selected from H, halogen, C-alkyl, halogen-C-alkyl, aryl-C-alkyl, C-cycloalkyl-C-alkyl, COOH, C (O) NR8′R9 ′, acyl, OR7, SR7, NR8R9, N-acyl, N-sulfonyl, cyano and SOR10 ; R is selected from H, halogen, C-alkyl, aryl-C-alkyl, C-cycloalkyl-C-alkyl, acyl, OR7, SR7, NR8R9, N-acyl, N-sulfonyl, cyano and SOR10; R3 is selected from H, halogen, C-alkyl, halogen-C-alkyl, aryl-C-alkyl, C-cycloalkyl-C-alkyl, acyl, OR7, SR7, NR8R9, N-acyl, N-sulfonyl, cyano and SOR10; R4 represents H or C-alkyl; R5 and R6 are the same or different and are independently selected from H, C-alkyl, C-alkyl-S-C-alkyl, C-alkyl-O-C-alkyl, aryl and C-cycloalkyl or R5 and R6, together with the carbon atom to which they are attached, can form a C-carbocycle or heterocycle which is optionally substituted with a C-alkyl-SO group; V is S, O or SO, Z is selected from C-alkyl, aryl, optionally substituted with C-cycloalkyl, C-alkyl, C-alkoxy, halogen, halogen-C-alkoxy, C (O) N (C-alkyl, C-alkyl), C (O) NHSO-C-alkyl, C (O ) N (C-alkyl, hydroxy-C-alkyl), C (O) N (C-alkyl, COOH-C-alkyl), phenyl optionally substituted with cyano, COO-C-alkyl or COOH; aryl-C-alkyl, heteroaryl, optionally substituted with cyano, C-alkoxy, or phenyl, optionally substituted with C (O) N (H, C-alkyl), cyano or COOH, polycyclic aromatic
Claims (26)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261681337P | 2012-08-09 | 2012-08-09 | |
US61/681,337 | 2012-08-09 | ||
PCT/EP2013/066431 WO2014023708A1 (en) | 2012-08-09 | 2013-08-06 | Substituted hetero-azepinones |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2015105561A true RU2015105561A (en) | 2016-09-27 |
Family
ID=48951449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2015105561A RU2015105561A (en) | 2012-08-09 | 2013-08-06 | SUBSTITUTED HETEROAZEPINONES |
Country Status (11)
Country | Link |
---|---|
US (1) | US9394263B2 (en) |
EP (1) | EP2882725A1 (en) |
JP (1) | JP6266617B2 (en) |
KR (1) | KR20150041647A (en) |
CN (1) | CN104470905B (en) |
BR (1) | BR112015001830A2 (en) |
CA (1) | CA2877048A1 (en) |
HK (1) | HK1206740A1 (en) |
MX (1) | MX2015001720A (en) |
RU (1) | RU2015105561A (en) |
WO (1) | WO2014023708A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2015003188A (en) * | 2012-09-19 | 2015-07-17 | Hoffmann La Roche | 2-oxo-2,3,4,5-tetrahydro-1 h-benzo[b]diazepines and their use in the treatment of cancer. |
WO2016079527A1 (en) | 2014-11-19 | 2016-05-26 | Tetralogic Birinapant Uk Ltd | Combination therapy |
WO2016097773A1 (en) | 2014-12-19 | 2016-06-23 | Children's Cancer Institute | Therapeutic iap antagonists for treating proliferative disorders |
NZ737297A (en) | 2015-07-02 | 2024-03-22 | Hoffmann La Roche | Bicyclic lactams and methods of use thereof |
CN106467521A (en) * | 2015-08-14 | 2017-03-01 | 陈志龙 | Two kinds of preparation methoies of one class bisbenzimidazole indole derivativeses |
CN106467515B (en) * | 2015-08-18 | 2019-09-24 | 宁波洞密生物科技有限公司 | Application of a kind of 6- pyridine benzimidazole indole derivatives and preparation method thereof with field of medicaments |
EP3414239A2 (en) | 2016-02-05 | 2018-12-19 | Denali Therapeutics Inc. | Inhibitors of receptor-interacting protein kinase 1 |
JP7349359B2 (en) | 2016-10-17 | 2023-09-22 | エフ. ホフマン-ラ ロシュ アーゲー | Bicyclic pyridone lactams and methods of using them. |
PL3552017T3 (en) | 2016-12-09 | 2022-08-08 | Denali Therapeutics Inc. | Compounds useful as ripk1 inhibitors |
US11072607B2 (en) | 2016-12-16 | 2021-07-27 | Genentech, Inc. | Inhibitors of RIP1 kinase and methods of use thereof |
CN112074519A (en) | 2018-04-20 | 2020-12-11 | 豪夫迈·罗氏有限公司 | N- [ 4-oxo-2, 3-dihydro-1, 5-benzoxazepin-3-yl ] -5, 6-dihydro-4H-pyrrolo [1,2-B ] pyrazole-2-carboxamide derivatives and related compounds as RIP1 kinase inhibitors for the treatment of e.g. Irritable Bowel Syndrome (IBS) |
JPWO2020027225A1 (en) | 2018-07-31 | 2021-11-11 | ファイメクス株式会社 | Heterocyclic compound |
JPWO2021020585A1 (en) | 2019-07-31 | 2021-02-04 | ||
PE20231505A1 (en) * | 2021-02-12 | 2023-09-26 | Hoffmann La Roche | BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER |
WO2023030295A1 (en) * | 2021-09-01 | 2023-03-09 | 先声再明医药有限公司 | Ubiquitin specific protease 1 (usp1) inhibitor |
WO2023150790A2 (en) * | 2022-02-07 | 2023-08-10 | The Wistar Institute Of Anatomy And Biology | Novel and highly selective sars-cov-2 mpro inhibitors |
WO2024033388A1 (en) * | 2022-08-11 | 2024-02-15 | F. Hoffmann-La Roche Ag | Bicyclic tetrahydrothiazepine derivatives |
WO2024033458A1 (en) * | 2022-08-11 | 2024-02-15 | F. Hoffmann-La Roche Ag | Bicyclic tetrahydroazepine derivatives |
WO2024033457A1 (en) * | 2022-08-11 | 2024-02-15 | F. Hoffmann-La Roche Ag | Bicyclic tetrahydrothiazepine derivatives |
WO2024033389A1 (en) * | 2022-08-11 | 2024-02-15 | F. Hoffmann-La Roche Ag | Bicyclic tetrahydrothiazepine derivatives |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9420763D0 (en) | 1994-10-14 | 1994-11-30 | Glaxo Inc | Acetamide derivatives |
TW200502221A (en) * | 2002-10-03 | 2005-01-16 | Astrazeneca Ab | Novel lactams and uses thereof |
JP2008523141A (en) * | 2004-12-14 | 2008-07-03 | アストラゼネカ・アクチエボラーグ | New molecular probe |
WO2006133147A2 (en) | 2005-06-08 | 2006-12-14 | Novartis Ag | Organic compounds |
WO2007101347A1 (en) * | 2006-03-07 | 2007-09-13 | Aegera Therapeutics Inc. | Bir domain binding compounds |
US20090054398A1 (en) * | 2006-03-10 | 2009-02-26 | Astrazeneca Ab | Chemical compounds |
US20100144715A1 (en) * | 2007-02-28 | 2010-06-10 | Hoyt Scott B | Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel Blockers |
-
2013
- 2013-08-06 CN CN201380035993.XA patent/CN104470905B/en not_active Expired - Fee Related
- 2013-08-06 RU RU2015105561A patent/RU2015105561A/en not_active Application Discontinuation
- 2013-08-06 KR KR20157005929A patent/KR20150041647A/en not_active Application Discontinuation
- 2013-08-06 JP JP2015525858A patent/JP6266617B2/en not_active Expired - Fee Related
- 2013-08-06 CA CA2877048A patent/CA2877048A1/en not_active Abandoned
- 2013-08-06 WO PCT/EP2013/066431 patent/WO2014023708A1/en active Application Filing
- 2013-08-06 MX MX2015001720A patent/MX2015001720A/en unknown
- 2013-08-06 EP EP13747659.4A patent/EP2882725A1/en not_active Withdrawn
- 2013-08-06 BR BR112015001830A patent/BR112015001830A2/en not_active IP Right Cessation
- 2013-08-06 US US14/418,383 patent/US9394263B2/en not_active Expired - Fee Related
-
2015
- 2015-07-31 HK HK15107346.9A patent/HK1206740A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN104470905A (en) | 2015-03-25 |
BR112015001830A2 (en) | 2017-07-04 |
JP6266617B2 (en) | 2018-01-24 |
MX2015001720A (en) | 2015-04-14 |
KR20150041647A (en) | 2015-04-16 |
HK1206740A1 (en) | 2016-01-15 |
JP2015528821A (en) | 2015-10-01 |
CN104470905B (en) | 2017-09-12 |
US9394263B2 (en) | 2016-07-19 |
CA2877048A1 (en) | 2014-02-13 |
WO2014023708A1 (en) | 2014-02-13 |
US20150361059A1 (en) | 2015-12-17 |
EP2882725A1 (en) | 2015-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2015105561A (en) | SUBSTITUTED HETEROAZEPINONES | |
JP2015528821A5 (en) | ||
CY1120179T1 (en) | HYDROCYCLIC COMPOUND CONTAINING NITROGEN OR SALT THIS | |
ES2675022T3 (en) | Indolamine 2,3-dioxygenase inhibitors (IDO) | |
PE20230161A1 (en) | INHIBITORS OF MUTANT KRAS PROTEINS | |
ES2617619T3 (en) | Drug combinations comprising a DGAT inhibitor and a PPAR agonist | |
RU2373209C2 (en) | Pyrrolotriazine compounds as kinase inhibitors | |
EA200601287A1 (en) | DERIVATIVES (3-OXO-3,4-DIHYDROCHINOXALIN-2-ILAMINO) BENZAMIDE AND RELATED COMPOUNDS AS GLYCOGEN PHOSPHORILASE INHIBITORS FOR TREATING DIABETES AND OBSERVATION | |
PE20050020A1 (en) | DERIVATIVES 4- (2-OXO-2,3-DIHYDRO-1-H-IMIDAZO [4,5-b] PYRIDIN-1-IL) -N- (2-OXO-AZEPAN-3-IL) PIPERIDINIL-1- CARBOXAMIDE SUBSTITUTED AS CGRP RECEPTOR ANTAGONISTS | |
PE20061156A1 (en) | BENZAMIDE DERIVATIVES AS INHIBITING AGENTS OF THE GLYCINE TRANSPORTER | |
PE20151249A1 (en) | PYRAZOLOPYRIMIDINE DERIVATIVES AS INHIBITORS OF JAK KINASES | |
PE20142216A1 (en) | INDAZOLE INHIBITORS FROM THE WNT SIGNALING ROUTE AND THERAPEUTIC USES OF THE SAME | |
TW200745029A (en) | Sulfonamide derivatives exhibiting PGD2 receptor antagonism | |
TW200800938A (en) | Indole carboxylic acid derivatives exhibiting PGD2 receptor antagonism | |
PE20141700A1 (en) | 2- (2,4,5-ANILINE SUBSTITUTED) PYRIMIDINE COMPOUNDS | |
JP2012520867A5 (en) | ||
JP2015503507A5 (en) | ||
PE20121352A1 (en) | HETEROARYL DERIVATIVES CONTAINING N AS INHIBITORS OF KINASE JAK3 | |
PE20051095A1 (en) | 1H-HAVE [2,3-c] PIRAZOLE DERIVATIVES USEFUL AS KINASE INHIBITORS | |
PE20100737A1 (en) | NEW COMPOUNDS | |
PE20140966A1 (en) | QUINAZOLINE CARBOXAMIDE AZETHYDINES | |
PE20130611A1 (en) | SUBSTITUTE TRIAZOLOPYRIDINES | |
PE20081351A1 (en) | QUINAZOLINE DERIVATIVES AS ANTI-CANCER AGENTS | |
AU2017239625B2 (en) | Novel heterocyclic carboxamides as modulators of kinase activity | |
NZ601077A (en) | Use of an adrenal hormone-modifying agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20171025 |